InsidersTradesSigma
Discover the detailed record of transactions filed by Moss Ronald B., Directeur Médical. Director active across 1 companies, notably Adamis Pharmaceuticals Corp. Cumulatively, 3 reports have been logged. Total volume traded: €54k. The latest transaction was disclosed on 18 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Ronald B. Moss serves as Chief Medical Officer at Adamis Pharmaceuticals Corp. He is responsible for medical strategy and research, ensuring that the company's products meet quality and safety standards. Ronald plays a key role in developing new therapies and in medical innovation.